Mutations in Clotting Factors and Inflammatory Bowel Disease

@article{Bernstein2007MutationsIC,
  title={Mutations in Clotting Factors and Inflammatory Bowel Disease},
  author={Charles N. Bernstein and Michael Sargent and Hans L. Vos and Frits Richard Rosendaal},
  journal={The American Journal of Gastroenterology},
  year={2007},
  volume={102},
  pages={338-343}
}
BACKGROUND:Patients with Crohn's disease (CD) and ulcerative colitis (UC) have a three- to fourfold greater risk of venous thrombosis compared with the general population. We aimed to determine if patients with CD and UC had a greater likelihood of mutations in genes that increase clotting risk, in a population-based case–control study.METHODS:Subjects were drawn from the University of Manitoba IBD Research Registry and controls were drawn from Manitoba Health's administrative database. Cases… 

Tables from this paper

Thromboembolic Events in Patients with Inflammatory Bowel Disease

  • F. AlgahtaniY. Farag M. Shoukri
  • Medicine
    Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
  • 2016
In a population with high consanguinity, Thromboembolic events (DVT and PE) had a prevalence of 8% among IBD patients, and positive family history of pulmonary embolism was a predictor of thrombosis.

Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?

The MTHFR 677TT mutation, factor V Leiden, and the prothrombin G20210A mutation are not associated with fibrostenosis in Crohn's disease.

Thrombosis and inflammatory bowel disease-the role of genetic risk factors.

The current data and future prospects on the role of genetic risk factors in the development of thromboembolism in IBD are reviewed.

Severe Activity and Cytomegalovirus Colitis May Increase Risk of Venous Thromboembolism in Inflammatory Bowel Disease

The incidence of VTE seems to be lower in Asian than in Western patients, and higher disease activity is associated with an increased risk of developing VTE and CMV colitis may also increase this risk.

Thrombosis in inflammatory bowel diseases: what’s the link?

The role of platelets and microvascular endothelium has been reviewed, as the possible link between the inflammatory and hemostatic process, and both quantitative and qualitative alterations have been demonstrated.

Chapter 7 Functional polymorphisms in the blood coagulation factor F 13 A 1 gene and inflammatory bowel disease in the Netherlands

Two common non-synonymous polymorphisms in the gene encoding coagulation factor XIII, A1 polypeptide F13A1 Val34Leu and F13 a1 Pro564Leu are associated with thrombotic diseases and were investigated for their role in the susceptibility to and severity of IBD.

IL-23R Determines Susceptibility in Crohn's Disease in a

In this large study population co-lonic involvement in IBD patients did notpredispose to thromboembolism, however, venousTE was associated with the well-known thrombotic risk factor of older age as well as longer duration of disease in CD andexten-sive UC.

IL-23R determines susceptibility in Crohn's disease in a Mediterranean area.

In this large study population colonic involvement in IBD patients did not predispose to thromboembolism and the majority of both patients with and without TE had colonic involved in CD and extensive UC, respectively, however, venous TE was associated with the well-known thrombotic risk factor of older age as well as longer duration of disease and intestinal resections in CD.
...

References

SHOWING 1-10 OF 43 REFERENCES

Inflammatory Bowel Diseases Are Not Associated with Major Hereditary Conditions Predisposing to Thrombosis

The study shows no association between IBD and the most frequent hereditary prothrombotic conditions, and other factors should be evaluated in order to understand the mechanisms underlying the thromboembolic risk of IBD.

High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease

Higher prevalences of single and combined thrombophilic defects were found in inflammatory bowel disease patients, factors that could be involved in the disease pathogenesis.

Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease

High homocysteine and high serum folate may be associated with low vitamin B12 levels in IBD patients and both hyperhomocysteinaemia and a low APC ratio may contribute to an increased risk of thromboembolic disease in I BD patients.

Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications

There is an association between the thermolabile MTHFR C677T variant and IBD, which accounts in part for the raised plasma tHcy found in patients with IBD and may contribute to the increased incidence of thromboembolic complications.

Arg506Gln factor V mutation and Val34Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease.

Clinical features of IBD, including the disease extent, requirement for immunosuppressive drugs, and occurrence of complications, seemed to be independent of these two clotting factor variants analyzed.

Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease.

  • S. SaibeniM. Vecchi R. de Franchis
  • Medicine
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2003

Hyperhomocysteinaemia, Coagulation Pathway Activation and Thrombophilia in Patients with Inflammatory Bowel Disease

No significant difference could be found in coagulation activity, acute-phase reactants or inflammatory markers in IBD patients with the TT variant of the 677C → T polymorphism or high (>15 μmol/L) plasma HCY levels, compared with patients with no impairment of HCY metabolism.

Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations in patients with inflammatory bowel disease.

Hyperhomocysteinemia is associated with IBD and low folate levels, and could be involved in development of thromboembolism, and MTHFR 677C-->T and 1298A-->C mutations are not related with the disease.

Significance of Diminished Factor XIII in Crohn's Disease

It is suggested that a low factor XIIIA level is related to the presence of intestinal lesions and might be linked to intestinal repair mechanisms; loss in intestinal lumen could be also involved, especially in patients with intestinal bleeding.